Bioavailability Comparison Metrics
Bioavailability Comparison Metrics is a quantitative analytical framework used in pharmacokinetics to systematically evaluate and contrast the rate and extent of drug absorption between different formulations or administration routes by normalizing test product performance relative to a reference standard.
23
Publications
758
Citations
123
Authors
42
Institutions
Publications per year
2017–2026
4
Parents
23
Bioavailability of IgG Administered by the Subcutaneous Route
Melvin Berger, Stephen Jolles, Jordan S. Orange et al. · Journal of Clinical Immunology · 2013 · 87 citations · Full text
An individual bioequivalence criterion: regulatory considerations
Mei‐Ling Chen, Rabindra Patnaik, Walter W. Hauck et al. · Statistics in Medicine · 2000 · 61 citations
Nguyen-Thach Tung, Cao-Son Tran, Thi-Minh-Hue Pham et al. · International Journal of Pharmaceutics · 2017 · 51 citations
Ebi K. Kimanani, Daria Stypinski, Gary Curtis et al. · The Journal of Clinical Pharmacology · 2000 · 48 citations
1–5 of 23
123
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 123
42
Baylor College of Medicine
Houston, United States
1 h-index
1 publications
87 citations
Kishokai Medical Corporation
Nagoya, Japan
1 h-index
1 publications
11 citations
Texas Children's Hospital
Houston, United States
1 h-index
1 publications
87 citations
Center for Drug Evaluation and Research
Silver Spring, United States
1 h-index
6 publications
366 citations

Ruijin Hospital
Shanghai, China
1 h-index
9 publications
126 citations

Gachon University
Seongnam-si, South Korea
1 h-index
1 publications
51 citations
CSL (Switzerland)
Bern, Switzerland
1 h-index
1 publications
87 citations

University of Maryland, Baltimore
Baltimore, United States
1 h-index
2 publications
48 citations
1–8 of 42
2 publications · 50 citations
2
h-index
2 publications · 71 citations
2
h-index
Repository · 3 publications · 53 citations
2
h-index
ESPR · 1 publications · 16 citations
1
h-index
1 publications · 24 citations
1
h-index
1–5